Correlation Between Hookipa Pharma and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Edgewise Therapeutics, you can compare the effects of market volatilities on Hookipa Pharma and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Edgewise Therapeutics.
Diversification Opportunities for Hookipa Pharma and Edgewise Therapeutics
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hookipa and Edgewise is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Edgewise Therapeutics
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Edgewise Therapeutics. In addition to that, Hookipa Pharma is 1.85 times more volatile than Edgewise Therapeutics. It trades about -0.49 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 3,404 in Edgewise Therapeutics on August 28, 2024 and sell it today you would lose (206.00) from holding Edgewise Therapeutics or give up 6.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hookipa Pharma vs. Edgewise Therapeutics
Performance |
| Timeline |
| Hookipa Pharma |
| Edgewise Therapeutics |
Hookipa Pharma and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Edgewise Therapeutics
The main advantage of trading using opposite Hookipa Pharma and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |